Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation. [electronic resource]
Producer: 20080131Description: 1295-6 p. digitalISSN:- 1592-8721
- Adult
- Antineoplastic Agents -- therapeutic use
- Boronic Acids -- therapeutic use
- Bortezomib
- Female
- Follow-Up Studies
- Graft vs Host Disease -- prevention & control
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Multiple Myeloma -- complications
- Neoplasm Recurrence, Local -- drug therapy
- Pyrazines -- therapeutic use
- Salvage Therapy
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Letter
There are no comments on this title.
Log in to your account to post a comment.